期刊
CANCER CELL
卷 35, 期 4, 页码 545-557出版社
CELL PRESS
DOI: 10.1016/j.ccell.2019.01.019
关键词
-
资金
- Swiss National Science Foundation through the National Center of Competence in Research (NCCR) RNA Disease''
- University Hospital of Bern
- Helmut Horten Stiftung
- Swiss Cancer League
- Medical Faculty of the University
Long non-coding RNAs (lncRNAs) represent a huge reservoir of potential cancer targets. Such onco-lncRNAs have resisted traditanal RNAi methods, but CRIrPR-Cas9 genome editing now promises functional screens at high throughput and low cost. The unique biology of lncRNAs demands screening strategies distinct from protein-coding genes. The first such screens have identified hundreds of onco-lncRNAs promoting cell proliferation and drug resistance. Ongoing developments will further improve screen performance and translational relevance. This Review aims to highlight the potential of CRISPR screening technology for discovering new onco-lncRNAs, and to guide molecular oncologists wishing to apply it to their cancer of interest.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据